Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
25.36
+0.35 (1.40%)
At close: Feb 6, 2026, 4:00 PM EST
24.87
-0.49 (-1.93%)
After-hours: Feb 6, 2026, 6:42 PM EST
Olema Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$41.14
Upside
+62.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +77.44% | Jan 7, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $21 → $60 | Strong Buy | Maintains | $21 → $60 | +136.59% | Dec 12, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $45 → $48 | Buy | Maintains | $45 → $48 | +89.27% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $26 → $38 | Strong Buy | Maintains | $26 → $38 | +49.84% | Dec 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $45 | Strong Buy | Maintains | $36 → $45 | +77.44% | Dec 11, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $26 | Strong Buy | Maintains | $18 → $26 | +2.52% | Nov 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $28 → $36 | Strong Buy | Maintains | $28 → $36 | +41.96% | Nov 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $45 | Buy | Maintains | $22 → $45 | +77.44% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $29 → $32 | Buy | Maintains | $29 → $32 | +26.18% | Nov 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +10.41% | Oct 20, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | -21.14% | Oct 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $22 | Buy | Maintains | $22 | -13.25% | Sep 3, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $28 → $29 | Buy | Maintains | $28 → $29 | +14.35% | Aug 14, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $20 → $21 | Strong Buy | Maintains | $20 → $21 | -17.19% | Aug 12, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | -29.02% | May 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 → $22 | Buy | Maintains | $25 → $22 | -13.25% | May 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.